Skip to main content

Sreekanth Vemulapalli

Associate Professor of Medicine
Medicine, Cardiology
Box 3126 Medical Center, Durham, NC 27710
2301 Erwin Rd, Room 7451 D, Durham, NC 27710

Current Appointments & Affiliations


Associate Professor of Medicine · 2025 - Present Medicine, Cardiology, Medicine
Member in the Duke Clinical Research Institute · 2016 - Present Duke Clinical Research Institute, Institutes and Centers
Core Faculty Member, Duke-Margolis Institute for Health Policy · 2024 - Present Duke-Margolis Institute for Health Policy, University Institutes and Centers

In the News


Published April 4, 2019
Hospitals That Perform More Heart TAVR Surgeries Have Better Success. That's Important for Medicare Policy

View All News

Recent Publications


Outcomes of Patients With New Left Bundle Branch Block After TAVR: TVT Registry Insights.

Journal Article Circ Cardiovasc Interv · January 2, 2026 BACKGROUND: Cardiac conduction disturbances remain the most frequent complication of transcatheter aortic valve replacement (TAVR), but the clinical implications of new left bundle branch block (LBBB) after TAVR remain controversial. Here, we aim to assess ... Full text Link to item Cite

Prediction of Heart Failure Hospitalization or Death After TAVR.

Journal Article Circ Cardiovasc Interv · December 31, 2025 BACKGROUND: Heart failure (HF) remains a significant burden following transcatheter aortic valve replacement, adversely impacting survival and quality of life. Identification of patients who may benefit from closer monitoring or adjunctive medical therapy ... Full text Link to item Cite

Will a Conservative Case Selection Strategy Improve Hospital-Level TAVR Performance Metrics?

Journal Article Circ Cardiovasc Interv · December 4, 2025 BACKGROUND: Current national performance metrics rank transcatheter aortic valve replacement (TAVR) centers based on risk-adjusted outcomes. This could make operators/centers less inclined to offer TAVR in high-risk cases. METHODS: We used simulation model ... Full text Link to item Cite
View All Publications

Recent Grants


2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)

ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2023 - 2030

2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029

View All Grants

Education, Training & Certifications


Duke University, School of Medicine · 2005 M.D.